| Profile | GDS4177 / 210312_s_at |
| Title | Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1 |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM603100 | KU-812 Imatinib-treated | 640.03 | 92 |
| GSM603099 | KU-812 non-treated | 450.28 | 89 |
| GSM603098 | KCL-22 Imatinib-treated | 658.09 | 92 |
| GSM603097 | KCL-22 non-treated | 255.29 | 82 |
| GSM603102 | JURL-MK1 Imatinib-treated | 678.08 | 92 |
| GSM603101 | JURL-MK1 non-treated | 396.98 | 87 |